{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:12:08Z","timestamp":1790097128853,"version":"4.0.1"},"reference-count":16,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,10,31]],"date-time":"2005-10-31T00:00:00Z","timestamp":1130716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2006,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Calcipotriol and betamethasone dipropionate are both proven products in the topical treatment of psoriasis. The efficacy and tolerability of a new ointment containing these two compounds has been assessed in six phase\u00a0III clinical studies.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> To compare the results obtained in the clinical studies of the new calcipotriol\/betamethasone dipropionate ointment.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> A total of 6050 patients with psoriasis took part in the six randomized, double\u2010blind studies. The two\u2010compound product was compared with each of the active constituents, either in the new ointment vehicle or in the marketed formulation.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> After 4\u00a0weeks of treatment the mean reduction in the Psoriasis Area and Severity Index (PASI) ranged from 65 to 74% with the two\u2010compound product applied once or twice daily, from 46 to 59% with calcipotriol alone and from 57 to 63% with betamethasone dipropionate alone. The tolerability profile of the two\u2010compound product was similar to betamethasone dipropionate monotherapy and better than calcipotriol alone.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> The new two\u2010compound product containing calcipotriol and betamethasone dipropionate was found to consistently provide rapid, highly effective treatment of psoriasis vulgaris.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2005.01343.x","type":"journal-article","created":{"date-parts":[[2005,10,31]],"date-time":"2005-10-31T16:40:52Z","timestamp":1130776852000},"page":"39-44","source":"Crossref","is-referenced-by-count":37,"title":["Consistency of data in six phase\u00a0III clinical studies of a two\u2010compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis"],"prefix":"10.1111","volume":"20","author":[{"given":"K","family":"Kragballe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PCM","family":"Van De Kerkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,10,31]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503023320907"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70112-X"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70103-M"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92157-W"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247323"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb00126.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb04981.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70237-3"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.d01-1148.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02461.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000066440"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04967.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.130"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015550252948194"},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","unstructured":"KragballeK NoerrelundK LuiHet al.Efficacy of once daily treatment regimens with calcipotriol\/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.Br J Dermatol2004;150:1167\u20131173.","DOI":"10.1111\/j.1365-2133.2004.05986.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","unstructured":"OrtonneJP KaufmannR LechaM GoodfieldM.Efficacy of treatment with calcipotriol\/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised double\u2010blind trial.Dermatology2004;209:308\u2013313.","DOI":"10.1159\/000080854"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2005.01343.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T22:31:28Z","timestamp":1697063488000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2005.01343.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,31]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["10.1111\/j.1468-3083.2005.01343.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2005.01343.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,31]]}}}